66.54
+8.53%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bruker
From its filings with the US Securities and Exchange Commission
Bruker is based in Billerica, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker BRKR. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $3.44bn and a net loss of $8.6m. At that date it held total assets of $6.24bn and shareholders' equity of $2.46bn.
We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples. Our products and solutions address the rapidly evolving needs of a diverse array of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. Our technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies. We are enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research and offer differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. Our corporate headquarters are located in Billerica, Massachusetts. We maintain major technical and manufacturing centers in Europe and North America and have sales offices located throughout the world.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 4 Aug 2000
- Employees
- 11,085
- Website
- bruker.com ↗
- Head office
- 40 MANNING RD, BILLERICA, MA, 01821
- Incorporated in
- DE
- Classification
- Laboratory Analytical Instruments
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Frank LaukienChairman of the Board, President, Chief Executive Officer, since 1991$5.5m
- Mr. Gerald HermanChief Financial Officer, Executive Vice President$2.3m
- Dr. Falko BussePresident - Bruker BioSpin Group$1.5m
- Dr. Burkhard PrausePresident and Chief Executive Officer - Bruker Energy and Supercon Technologies, Inc$967,913
- Mr. Juergen SregaPresident of Bruker CALID Group and Bruker Daltonics Division$1.5m
- Dr. Mark MunchExecutive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division$2.6m
- Mr. William LintonLead Independent Director$267,535
- Ms. Bonnie AndersonIndependent Director$255,535
- Ms. Laura FrancisIndependent Director$236,209
- Dr. Cynthia FriendIndependent Director$250,535
- Mr. John OrnellIndependent Director$272,535
- Mr. Richard PackerIndependent Director$257,535
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 76
- Environment
- 75
- Social
- 90
- Governance
- 64
- Direct emissions (scope 1)
- 3,621 t
- Energy emissions (scope 2)
- 10,426 t
- Carbon reduction policy
- No
- Human rights policy
- Yes
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.